Bacteremia associated with bronchoscopy  by El Batrawy, Sherouk et al.
Egyptian Journal of Chest Diseases and Tuberculosis (2014) 63, 701–704The Egyptian Society of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis
www.elsevier.com/locate/ejcdt
www.sciencedirect.comORIGINAL ARTICLEBacteremia associated with bronchoscopy* Corresponding author. Tel.: +20 1223130880.
E-mail address: Sheroukhh@yahoo.com (S. El Batrawy).
Peer review under responsibility of The Egyptian Society of Chest
Diseases and Tuberculosis.
Production and hosting by Elsevier
0422-7638 ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
http://dx.doi.org/10.1016/j.ejcdt.2014.03.002Open access under CC BY-NC-ND license.Sherouk El Batrawy a,*, Gehan Elassal a, Ahmed Moustafa b, Hala Hafez ca Chest Department, Ain Shams University, Cairo, Egypt
b Thoracic Surgery Department, Ain Shams University, Cairo, Egypt
c Clinical Pathology Department, Ain Shams University, Cairo, EgyptReceived 19 January 2014; accepted 4 March 2014
Available online 1 April 2014KEYWORDS
Bacteremia;
BronchoscopeAbstract Objective: To assess the incidence of bacteremia following bronchoscopy to determine
whether the use of prophylactic antibiotics is warranted in patients at risk of endocarditis.
Design: Prospective nonrandomized clinical study.
Settings: Bronchoscopy Unit of Chest Department and Thoracic Surgery Department, and
Microbiology Laboratory of Ain Shams University Hospitals, Cairo, Egypt.
Patients: Forty-ﬁve patients undergoing diagnostic and therapeutic bronchoscopy.
Interventions: Blood samples for culture were obtained before and immediately after the
procedure.
Results: There were no documented cases of bacterial growth in blood. Two culture bottles
yielded contaminant.
Conclusion: Bronchoscopy is a low-risk procedure for the development of bacteremia. This may
bear on present practice regarding perioperative antibiotic prophylaxis for endocarditis in the
high-risk groups.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Bacteraemia is a well-recognized consequence of invasive
medical procedures as well as simple day to day living activities
like teeth brushing. In most cases, it is a transient phenomenon
without clinical consequences [1]. In certain patients, such asthose with structural cardiac abnormalities, it is thought that
it may lead to the development of infective endocarditis (IE)
[2].
Current NICE guidelines recommend that antibiotic
prophylaxis is no longer offered routinely for patients under-
going bronchoscopy because it has not been proven to be
effective and there is no clear association between episodes
of infective endocarditis and interventional procedures [3].
Furthermore, the predisposing factors for the development
of IE in western countries have changed in the past 50 years,
mainly with the decreasing incidence of rheumatic heart
disease and the increasing impact of prosthetic heart valves,
nosocomial infection and intravenous drug misuse. However,
the potentially serious impact of IE on the individual has not
changed [4].
Table 1 Characteristics of studied patients.
Children Adults Total
Males 4 29 33
Females 5 7 12
Total 9 36 45
Nine patients were children (under 16 years of age) and 36 were
adults. There were 37 males and 8 females.
Table 2 Age of studied population.
Mean (years) SD (years)
Children 12.3 ±2.8
Adults 48 ±13.75
The age of patients ranged from 8 to 65 years. Children had a mean
age of 12.3 ± 2.8 while adults had a mean age of 48 ± 13.75.
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ondary to rheumatic fever is not an uncommon ﬁnding the
beneﬁts from prophylaxis need to be weighed against the costs
of administering care, risks of adverse effects for the patient
and of the development of antibiotic resistance.
So, the aim of the current study was to assess the frequency
of bacteremia following the bronchoscopy procedure.
Patients and methods
The study was carried out at the bronchoscopy suite in the
Chest Department, Thoracic Surgery Department and
Microbiology Laboratory of Ain Shams University Hospitals,
Cairo, Egypt. The study population consisted of 45 consecu-
tive patients – all ambulatory – who underwent bronchoscopy
during the study period. Patients with current respiratory
tract infection or febrile illnesses and those receiving antibi-
otic therapy within a week prior to the bronchoscopy were
excluded.
A total of 14 patients underwent rigid bronchoscopy for
foreign body extraction. The remaining patients underwent
ﬂexible bronchoscopy for investigation of: non resolving pneu-
monia (4 patients); hemoptysis (9 patients); stridor (2 patients);
bronchiectasis (6 patients); chronic cough (6 patients);
suspected upper airway stenosis (3 patients); and mediastinal
mass (1 patient).
Rigid bronchoscopy was performed using Bryan
Corporation bronchoscopes. Patients were deeply sedated
and the bronchoscopy was performed.
Flexible bronchoscopy was performed transnasally using
ﬂexible, ﬁbreoptic bronchoscopes (Pentax, EB-18 30T3). The
bronchoscopy included a systematic review of the tracheo
bronchial tree. Endobronchial lesions were sampled using
cup shaped (Pentax) or toothed (Alligator) forceps (3 ± 5
biopsy specimens), followed by 2 ± 4 brush samples and
lavage with 50 ± 100 mL saline, using sterile negative pressure
suction. Pulmonary lesions beyond the range of the
bronchoscope were sampled by brushing followed by lavage.
Blood sampling: three 10 mL blood samples were taken
from the anti cubical fossa one immediately before and two
after bronchoscopy 10 min apart under complete aseptic
conditions.
Bacterial cultures
The 10 mL venous blood samples were inoculated, at bed side,
onto the BACTECTM PLUS Aerobic/F blood culture
medium which usually contains nutritive elements for
microorganisms, anticoagulant, and resins for the adsorption
of antibiotics. Bottles were then transported immediately to
the Microbiology Laboratory for further processing.
Bottles were put into the BACTEC 9050 series Instrument.
Growing microorganisms metabolize substrates in the medium
and release CO2. This produced CO2 is detected by a sensor in
the bottle which is monitored every 10 min by the BACTEC
9050 series Instrument for an increase in its ﬂuorescence, which
is proportional to the amount of CO2 in the bottle. The
presence of a positive ﬂag at the bottle position in the
instrument denotes the presence of microbial growth whereas
the appearance of a negative signal, after 5 days incubation,
denotes a negative growth.Positive bottles were removed from the BACTEC instru-
ment, mixed well by shaking, and a sample of 3–5 mL
blood/broth was aspirated from it under aseptic conditions
using a sterile syringe.
Routine subculture was done onto a blood agar plate, one
MacConkey agar plate and one Chocolate agar plate. The
MacConkey agar plate was incubated at 36 ± 1 C under
aerobic conditions, and the blood agar plate as well as the
chocolate agar plate were incubated at 36 ± 1 C under
aerobic conditions with added 5–10% CO2.
After 18–24 h incubation, plates were examined for the
presence of any relevant growth. The recovered organism
was then identiﬁed and their antimicrobial susceptibility was
determined in accordance to the Microbiology Laboratory
procedures.
If no growth appeared after 18–24 h incubation, plates were
re-incubated for additional 48 h and re-examined thereafter.
Negative bottles, as evidenced by the appearance of a
negative signal, were removed from the instrument and
examined for the presence of any evidence of microbial growth
(turbidity, hemolysis). If there was any evidence of microbial
growth, bottles were treated as positive bottles. If no evidence
of microbial growth exists bottles were discarded and reports
were discharged as no growth after 5 days incubation.
We deﬁned true bacteremia as episodes in which two post
bronchoscopy positive blood cultures yielded the same
organisms.
Results
Patient characteristics
Past medical history, comorbidity: 5 patients had cardiovascu-
lar disease, but none had clinical evidence of a cardiac valvular
deformity; 4 had impaired immunity due to diabetes, 8 had
chronic obstructive lung disease; 14 had no deﬁned comorbid-
ity (Tables 1 and 2).
Bronchoscopy ﬁndings
Twenty-two patients had a normal study 2 had subglottic
stenosis and 19 patients showed inﬂamed bronchial mucosa.
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Two culture bottles yielded contaminant. Overall no patients
had documented bacterial growth in blood.
DiscussionThis study examined the frequency of bacteraemia following
bronchoscopy in 45 consecutive patients. We hypothesized
that during bronchoscopy, bacteria are driven by the broncho-
scope from the upper to the lower airways. Mucosal damage
induced by the bronchoscope and/or the associated procedures
may facilitate penetration of bacteria into the blood stream.
True bacteraemia was recorded only for those patients in
whom two consecutive blood cultures showed the same
organism. This led to the exclusion of 2 bacteraemia episodes
(Staphylococcus coagulase negative) as contaminants. This
interpretation is supported by published data showing that
70% of all staphylococcus coagulase negative blood culture
isolates are regarded as contaminants [5]. Otherwise no
positive blood cultures were noted.
The rationale for prophylaxis against IE is: endocarditis
usually follows bacteraemia, certain interventional proce-
dures cause bacteraemia with organisms that can cause
endocarditis, these bacteria are usually sensitive to antibiot-
ics; therefore, antibiotics should be given to patients with
predisposing heart disease before procedures that may cause
bacteraemia [2].
The evidence base for the use of antibiotic prophylaxis for
infective endocarditis has relied heavily on extrapolation from
animal models of the disease [6] and the applicability of these
models to people has been questioned. With a rare but serious
condition such as IE it is difﬁcult to plan and execute research
using experimental study designs. Consequently, the evidence
available in this area is limited, being drawn chieﬂy from
observational (case–control) studies. Experimental animal
models have shown that bacteraemia can cause IE. However,
the intensity of bacteraemia used has been very high when
compared with those detected in both adults and children
following interventional dental procedures [7].
While in humans there is no consistent association between
having an interventional procedure, dental or non-dental, and
the development of IE, regular teeth brushing almost certainly
presents a greater risk of IE than a single dental procedure
because of repetitive exposure to bacteraemia with oral ﬂora
[8,9]. The clinical effectiveness of antibiotic prophylaxis is
not proven and antibiotic prophylaxis against IE may lead
to a greater number of deaths through fatal anaphylaxis than
a strategy of no antibiotic prophylaxis, and is not cost effective
[3]. For dental and non-dental procedures the studies showed
an inconsistent association between recent interventional
procedures and the development of infective endocarditis
[10–12]. The incidence of bacteraemia following upper and
lower gastrointestinal procedures varies between 2 ± 10%
[13]. While in ﬁbreoptic bronchoscopy there is no evidence to
link level, frequency and duration of bacteraemia with the
development of infective endocarditis [14].
As a result recent British [3], European [15], and American
[16] guidelines recommend that antibiotic prophylaxis
administered solely to prevent IE should not be given to peopleat risk of IE undergoing dental and non-dental procedures
including bronchoscopy.
AHA guideline [16] noted that conclusive links have not
been demonstrated between respiratory tract procedures and
IE. BSAC guideline [17] noted that there are no good epidemi-
ological data on the impact of bacteraemia from non-dental
procedures on the risk of developing endocarditis. The ESC
guideline [15] identiﬁed bacteraemia associated with respira-
tory, GI and GU procedures. The BCS/RCP guideline [18]
considered that evidence for signiﬁcant bacteraemia after
many GI, GU, respiratory or cardiac procedures had not been
proven, though it was noted that cases of IE have been
reported to follow these procedures.
The AHA guideline [16] also noted that few published
studies exist on the magnitude of bacteraemia after a dental
procedure or from routine daily activities, and most of the
published data used older, often unreliable microbiological
methodology. Furthermore, the BSAC guideline [17] high-
lighted that the signiﬁcance of both the magnitude and
duration of bacteraemia is unknown. In contrast, the BCS/
RCP guideline [18] considered that the risk of developing IE
is probably directly related to the frequency and severity of
bacteraemia that occurs with each individual procedure.
As a result guidelines by the British Society for
Antimicrobial Chemotherapy [17] and the American Heart
Association [16]have highlighted the prevalence of bacterae-
mias that arise from everyday activities such as tooth brushing,
the lack of association between episodes of IE and prior
interventional procedures, and the lack of efﬁcacy of antibiotic
prophylaxis regimens.
Our cohort of patients was consecutive and should be an
adequate representation of the population that undergoes
various types of bronchoscopy. However we do realize that
the spectrum of bronchoscopic invasive procedures has
increased off late some of which involve a substantial degree
of mucosal injury. Also a study that attempts to estimate the
incidence of a relatively infrequent phenomenon, such as
bacteraemia following bronchoscopy, should include a larger
number of patients.
A lack of data on upper airway ﬂora before the bronchos-
copy and the lack of correlation between the results of blood
and nasal and bronchial lavage cultures may be of signiﬁcance
if future studies focusing on more invasive procedures pick up
a relevant incidence rate of bacteremia.
Retrospective studies of patients with infective endocarditis
and whether they have undergone any procedure can expand
our knowledge should we attempt to recommend a best
practice guideline.
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